{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:40:41Z","timestamp":1773294041518,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development","award":["ZYLX 201403"],"award-info":[{"award-number":["ZYLX 201403"]}]}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.psychres.2017.04.013","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T03:29:46Z","timestamp":1491535786000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The efficacy and safety of aripiprazole for tic disorders in children and adolescents: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"254","author":[{"given":"Shuai","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Zhao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2017.04.013_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.1C297","article-title":"Aripiprazole: a new atypical antipsychotic drug","volume":"37","author":"Bowles","year":"2003","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.psychres.2017.04.013_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/0269881111408462","article-title":"Tolerability profile of aripiprazole in patients with Tourette syndrome","volume":"26","author":"Cavanna","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.04.013_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/cap.2009.0125","article-title":"Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China","volume":"20","author":"Cui","year":"2010","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.04.013_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fpsyt.2016.00097","article-title":"Comorbidities, social mpact, and quality of life in tourette syndrome","volume":"7","author":"Eapen","year":"2016","journal-title":"Front Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2017.04.013_bib5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00787-016-0823-8","article-title":"The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review","volume":"25","author":"Evans","year":"2016","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2017.04.013_bib6","first-page":"200","article-title":"Systemic review of aripiprazole for the treatment of children and adolescents with tic disorders","volume":"17","author":"Ghanizadeh","year":"2012","journal-title":"Neurosciences"},{"issue":"5","key":"10.1016\/j.psychres.2017.04.013_bib7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10578-013-0427-1","article-title":"Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial","volume":"45","author":"Ghanizadeh","year":"2014","journal-title":"Child Psychiatry Hum. Dev."},{"key":"10.1016\/j.psychres.2017.04.013_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2008.01.019","article-title":"Latent class analysis of gilles de la tourette syndrome using comorbidities: clinical and genetic implications","volume":"64","author":"Grados","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.04.013_bib9","first-page":"1213","article-title":"Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome","volume":"32","author":"Gulisano","year":"2011","journal-title":"Soc. Clin. Neurophysiol."},{"issue":"12","key":"10.1016\/j.psychres.2017.04.013_bib10","first-page":"1767","article-title":"Aripiprazole and haloperidol in the treatment of tic disorder of childhood","volume":"21","author":"Guo","year":"2013","journal-title":"China J. Health Psychol."},{"key":"10.1016\/j.psychres.2017.04.013_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1155\/2013\/626410","article-title":"Trials of pharmacological interventions for Tourette Syndrome: a systematic review","volume":"26","author":"Karen","year":"2013","journal-title":"Behav. Neurol."},{"issue":"2","key":"10.1016\/j.psychres.2017.04.013_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","article-title":"Prevalence of tic disorders: a systematic review and meta-analysis","volume":"47","author":"Knight","year":"2012","journal-title":"Pediatr. Neurol."},{"issue":"2","key":"10.1016\/j.psychres.2017.04.013_bib13","first-page":"111","article-title":"Comparative study of aripiprazole in the treatment of Tourette syndrome","volume":"36","author":"Liang","year":"2010","journal-title":"Chin. Nerv. Ment. Dis."},{"issue":"6","key":"10.1016\/j.psychres.2017.04.013_bib14","first-page":"421","article-title":"A control study of aripiprazole and tiapride treatment for tic disorders in children","volume":"12","author":"Liu","year":"2010","journal-title":"Chin. J. Contemp. Pediatr."},{"issue":"8","key":"10.1016\/j.psychres.2017.04.013_bib15","first-page":"572","article-title":"A multicenter controlled study on aripirazole treatment for children with Tourette syndrome in China","volume":"49","author":"Liu","year":"2011","journal-title":"Chin. J. Pediatr."},{"key":"10.1016\/j.psychres.2017.04.013_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-005-0008-8","article-title":"Tic disorders: from pathophysiology to treatment","volume":"253","author":"Rampello","year":"2006","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.psychres.2017.04.013_bib17","first-page":"222","article-title":"A comparative study of aripiprazole and haloperidol treatment for tic disorders in children","volume":"38","author":"Ren","year":"2012","journal-title":"Chin. J. Nerv. Ment. Dis."},{"issue":"4","key":"10.1016\/j.psychres.2017.04.013_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejpn.2011.12.001","article-title":"Treatment practices in Tourette syndrome: the European perspective","volume":"16","author":"Rickards","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"6","key":"10.1016\/j.psychres.2017.04.013_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pediatrneurol.2012.08.015","article-title":"Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome","volume":"47","author":"Rizzo","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.psychres.2017.04.013_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jpsychores.2009.07.010","article-title":"The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective","volume":"67","author":"Robertson","year":"2009","journal-title":"J. Psychosom. Res"},{"issue":"4","key":"10.1016\/j.psychres.2017.04.013_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2017.04.013_bib22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","article-title":"Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder","volume":"154","author":"Sallee","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.04.013_bib23","article-title":"A controlled study of the clinical effects of Duodongning capsule, Topiramate and Aripiprazole in the treatment of Tic disorder","author":"Su","year":"2015","journal-title":"China Natl. Knowl. Infrastruct. (CNKI)"},{"issue":"21","key":"10.1016\/j.psychres.2017.04.013_bib24","first-page":"64","article-title":"The clinical efficacy and safety of aripiprazole in the treatment of tic disorder","volume":"14","author":"Sun","year":"2014","journal-title":"China Med. Pharm."},{"issue":"12","key":"10.1016\/j.psychres.2017.04.013_bib25","first-page":"139","article-title":"The clinical efficacy of aripiprazole and topiramate in the treatment of Tourette's syndrome","volume":"36","author":"Wang","year":"2015","journal-title":"J. Med. Forum"},{"issue":"39","key":"10.1016\/j.psychres.2017.04.013_bib26","first-page":"58","article-title":"The efficacy of aripiprazole and tiapride for Tourette disorders in children","volume":"53","author":"Wang","year":"2013","journal-title":"Shandong Med. J."},{"key":"10.1016\/j.psychres.2017.04.013_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12888-015-0504-z","article-title":"Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis","volume":"15","author":"Yang","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2017.04.013_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00787-010-0154-0","article-title":"Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders","volume":"20","author":"Yoo","year":"2011","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2017.04.013_bib29","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4088\/JCP.12m08189","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder","volume":"74","author":"Yoo","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2017.04.013_bib30","first-page":"1393","article-title":"A randomized, controlled study of aripiprazole and risperidone for tic disorders","volume":"30","author":"Zhang","year":"2015","journal-title":"Clin. Focus."},{"issue":"20","key":"10.1016\/j.psychres.2017.04.013_bib31","first-page":"44","article-title":"A comparative study of aripiprazole and tiapride treatment for tic disorders","volume":"54","author":"Zhang","year":"2014","journal-title":"Shandong Med."},{"issue":"29","key":"10.1016\/j.psychres.2017.04.013_bib32","first-page":"111","article-title":"The efficacy of aripiprazole and haloperidol treatment for tic disorders in children","volume":"8","author":"Zhao","year":"2011","journal-title":"World Health Dig. Med. Period."},{"issue":"14","key":"10.1016\/j.psychres.2017.04.013_bib33","first-page":"2995","article-title":"A comparative study of aripiprazole orally disintegrating tablets and haloperidol treatment for tic disorders","volume":"36","author":"Zheng","year":"2015","journal-title":"Jilin Med."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811632008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811632008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T22:50:17Z","timestamp":1535928617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517811632008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":33,"alternative-id":["S016517811632008X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2017.04.013","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of aripiprazole for tic disorders in children and adolescents: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2017.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}